News Alerts

27 Jan 2020 | 12:14 PM UTC

CAR: 3653 measles cases reported nationwide as of January 25

Central African Republic News Alert

Measles epidemic reaches 3653 cases, 53 dead as of January 25; take precautionary measures

TIMEFRAME expected from 1/27/2020, 12:00 AM until 1/30/2020, 11:59 PM (Africa/Bangui). COUNTRY/REGION Central African Republic


According to health authorities, at least 3653 people have been infected with measles between February 2019, and January 2020. At least 53 related deaths have been reported across the country in over this period across the country. Further spread of the disease is possible over the coming weeks.

Further spread of the disease is possible over the coming weeks.


Measles is a highly contagious viral disease that typically affects children. It is transmitted via droplets from the nose or mouth of infected persons. A symptom of measles is usually a high fever, which begins approximately ten to 12 days after exposure to the virus and lasts four to seven days. A runny nose, a cough, red and watery eyes, and small white spots inside the cheeks can develop in the initial stage. After several days, a rash erupts, usually on the face and upper neck. Over the course of about three days, the rash spreads, eventually reaching the hands and feet. The rash lasts for five to six days and then fades. On average, the rash occurs 14 days after exposure to the virus (within a range of seven to 18 days). A vaccine is available.


Individuals in the CAR are advised to ensure their measles vaccination is up to date (including booster shots) and to contact their doctor with any questions or concerns. Anyone experiencing the aforementioned symptoms is urged to seek immediate medical attention.


Copyright and Disclaimer
GardaWorld is the owner or licensee of all intellectual property rights in the material presented on this website. All such rights are reserved. The use of this website and its material is subject to the Terms of Use and accordingly you must not use any content from this website for commercial or other analogous purposes without our consent, including but not limited to any deep-linking or framing in order to copy, distribute, display or monitor any portion of the website. If you have any questions or are interested in distributing any content from this website, Contact us for more details.

Related news